RE:RE:PreMarket $5.62 thus far I have one theory but it is as evil as the recapitalization where Thomvest got their 71% share when other funding sources were available in late 2018/ early 2019. Tanking things on purpose and Thomvest/ SALP own this puppy? I can't think of any other reason to put that information out there. There is just no logical reason unless there is a surprise new direction announced this week but, on the same basis that material news should be reported immediately, why would they stagger the news of dropping IPF and not announcing that, for instance, kidney or liver results were surprisingly good. To follow tanking theory, Thomvest could go private and talk to Boehringher and one other for competitive tension and sell off PBI4050 based on 8 clinical studies in data room in summer of 2018 as Thomvest don't want to be in this anymore.
Steve33 wrote:
I totally agree. They are doing an incredible job at keeping the share price down. For what purpose. They own most of the shares so they should want it to shoot up. Any guesses as to why?